Core Viewpoint - Zhonghong Medical's stock price has declined, closing at 14.92 yuan with a drop of 3.24%, indicating a current state of underperformance since its IPO [1] Group 1: IPO and Initial Performance - Zhonghong Medical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on April 27, 2021, with an initial public offering of 41.67 million shares at a price of 48.59 yuan per share [1] - The stock reached a peak price of 159.80 yuan on its first trading day, marking the highest price since its listing [1] - Currently, the stock is in a state of decline, having fallen below its initial offering price [1] Group 2: Fundraising and Financials - The total amount raised from the IPO was 2.025 billion yuan, with a net amount of 1.896 billion yuan after expenses, exceeding the originally planned fundraising by 1.317 billion yuan [1] - The initial fundraising plan aimed to raise 580 million yuan for projects related to nitrile gloves and working capital [1] - The total issuance costs for the IPO were 128 million yuan, with underwriting fees accounting for 107 million yuan [1] Group 3: Dividend Distribution - In 2022, Zhonghong Medical announced a profit distribution plan, distributing 7.00 yuan in cash per 10 shares and increasing the total share capital by 9 million shares through capital reserve [2] - For 2021, the company distributed 30.00 yuan in cash per 10 shares and increased the total share capital by 13.33 million shares [2] - The 2024 profit distribution plan includes a cash dividend of 2.5 yuan per 10 shares and a capital reserve increase of 3.88 million shares, resulting in a total share capital of approximately 428.86 million shares [3]
中红医疗跌3.24% 2021年上市即巅峰超募13亿元